Research Article
The Impact of Hypertension and Metabolic Syndrome on Nitrosative Stress and Glutathione Metabolism in Patients with Morbid Obesity
Table 1
Clinical characteristics of the control, morbid obesity (OB), morbid obesity with hypertension (OB+HYP), and morbid obesity with metabolic syndrome (OB+MS). Data given as median (lower and upper confidence limit), , , , and indicate significant differences from the control; #, ##, and ### indicate significant differences from the morbid obesity (OB); alanine transaminase (ALT), aspartate transaminase (AST), body mass index (BMI), C-reactive protein (CRP), creatinine (Crea), diastolic blood pressure (DBP), high-density lipoprotein (HDL), hemoglobin (HGB), homeostatic model assessment of insulin resistance (HOMA-IR), low-density lipoprotein (LDL), red blood cell count (RBC), systolic blood pressure (SBP), triacylglycerol (TG), uric acid (UA), white blood cell count (WBC), waist-hip ratio (WHR).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||